Meyka Pro banner
Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd. (PAVS) Stock Overview

Explore Paranovus Entertainment Technology Ltd.’s financial performance, market position, analyst ratings, and future outlook.

PAVSNASDAQ
HealthcareMedical - Pharmaceuticals
$6.99
$0.37(5.59%)
U.S. Market opens in 52h 14m

Paranovus Entertainment Technology Ltd. (PAVS)

Meyka AI Score

Z

Key Financials

Market Cap6M
P/E Ratio-0.62
EPS (TTM)$-89.52
ROE-0.27%
Fundamental Analysis

AI Price Forecasts

1 Month$6.99
3 Months$4.00
1 Year Target$3.70

PAVS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Paranovus Entertainment Technology Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PAVS on the NASDAQ shows an RSI of 62.67, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.70 for the NASDAQ listing.

Key metrics behind Paranovus Entertainment Technology Ltd.'s NASDAQ-traded stock include a P/E ratio of -0.62 and a market capitalization of 6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PAVS on the NASDAQ.

Price Performance (NASDAQ: PAVS)

1-Day Change
5.59%
5-Day Change
24.38%
1-Month Change
41.21%
3-Month Change
-93.76%
6-Month Change
-99.56%
Year-to-Date (YTD) Change
-99.66%
1-Year Change
-99.99%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

516 951 9074
250 Park Avenue, New York, NY, 10177

Company Facts

280 Employees
IPO DateOct 25, 2019
CountryUS
Actively Trading

Frequently Asked Questions